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Introduction
The first Quality Chasm report of the Institute of 
Medicine’s (IOM), ‘To Err Is Human’ stated that 
medication-related errors accounted for 1 out of 
every 131 outpatient deaths and 1 out of 854 
inpatient deaths.1–3 Provision of medication 
entails prescribing, verifying, dispensing, admin-
istering, monitoring and reporting.4 Studies esti-
mate 68–75% of adverse drug events occur as a 
result of mistakes that occur during the prescrip-
tion stage with illegible handwriting contributing 
significantly to medication errors.5,6 Errors may 
arise from any of the several stages of the 
prescription process, with the risk being threefold 
greater for pediatric medications.5 Dosage calcu-
lation in children is based on age, weight, body 
surface area or severity of the clinical condition. 
In addition, children have a narrow therapeutic 
window and a lower physiological threshold for 
buffering overdose errors compared with adults. 
Children also lack capacity to participate effec-
tively in the medication process, thus placing 
them at greater risk for harm.2 The risk of medi-
cation errors is higher in outpatient settings where 
prescribers operating in a stressful work environ-
ment are less familiar with patients.
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Abstract
Background: Medication-related errors account for one out of every 131 outpatient deaths, 
and one out of 854 inpatient deaths. The risk is threefold greater in the pediatric population. In 
sub-Saharan Africa, research on medication-related errors has been obscured by other health 
priorities and poor recognition of harm attributable to such errors.
Our primary objective was to assess the effect of introduction of a voice recognition system 
(VRS) on the prevalence of medication errors. The secondary objective was to describe 
characteristics of observed medication errors and determine acceptability of VRS by clinical 
service providers.
Methods: This was a before–after intervention study carried out in a Pediatric Accident and 
Emergency Department of a private not-for-profit tertiary referral hospital in Kenya.
Results: A total of 1196 handwritten prescription records were examined in the pre-VRS phase 
and 501 in the VRS phase. In the pre-VRS phase, 74.3% of the prescriptions (889 of 1196) had 
identifiable errors compared with 65.7% in the VRS phase (329 of 501).
More than half (58%) of participating clinical service providers expressed preference for VRS 
prescriptions compared with handwritten prescriptions.
Conclusions: VRS reduces medication prescription errors with the greatest effect noted in 
reduction of incorrect medication dosages. More studies are needed to explore whether more 
training, user experience and software enhancement would minimize medication errors 
further. VRS technology is acceptable to physicians and pharmacists at a tertiary care hospital 
in Kenya.
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Interventions that have been used to reduce medi-
cation errors include enhancing knowledge on med-
ication safety, development of reporting systems 
and implementation of safety systems in healthcare 
organizations at the delivery level.2,7,8 Other inter-
ventions include use of tutorials, computerized phy-
sician order forms and workbooks.9–11 Electronic 
prescription systems have immediate benefits of 
improving legibility and completeness while elimi-
nating transcription errors.12–14 In VRS, voice is 
used to input data into the computer through a 
microphone. A computer software then converts 
voice data into text and stores it in a database, facili-
tating retrieval for subsequent use. Though readily 
available, VRS use in the medication process is 
largely unexplored.15,16 Kang and colleagues used 
Dragon® voice application to prepare pathology 
reports and demonstrated an 81% decrease in aver-
age turnaround time and a 48% decrease in the 
number of errors identified before signing out the 
report.15 Proper training followed by practice in 
VRS use is considered crucial for the success of 
voice recognition in reducing errors.17
Medication errors among the pediatric popula-
tion in sub-Saharan Africa remain largely under-
studied, hence there are limited data on 
effectiveness of various strategies to reduce medi-
cation errors in this region. The primary aim of 
this study was to determine if introduction of a 
voice recognition system (VRS) into the medica-
tion process would reduce the occurrence of pre-
scription errors in a pediatric Accident and 
Emergency (A&E) department at a tertiary care 
hospital in Kenya. Our secondary objectives were 
to describe the pattern of medication errors, fac-
tors associated with their occurrence and to deter-
mine acceptability of VRS by prescribing doctors 
and dispensing pharmacists.
Methods
Study design and setting
We conducted a before–after observational study 
at the Aga Khan University Hospital (AKUH) 
pediatric A&E department and main pharmacy. 
AKUH is a private ‘not-for-profit’ tertiary care 
hospital in Nairobi that mainly caters to middle- 
and high-income earners.
Study procedures
Retrospective chart review was used to ascertain 
prescription and dispensing errors among senior 
house officers (SHOs), resident trainees and clin-
ical instructors attending to clients at the pediat-
ric A&E department. SHOs are recently licensed 
but non-specialized doctors; residents are pediat-
ric trainees. Instructors are recently qualified 
pediatricians undergoing apprenticeship prior to 
licensing by the Kenya Medical Practitioners and 
Dentists Board. Doctors work in 6–12 hour shifts 
under supervision of the instructors but they all 
assess patients and prescribe independently.
A prescription error was defined as an omission 
or incorrect documentation of patient’s name, 
age, gender. Other errors included incorrect drug 
name, dose, route, frequency or duration as ascer-
tained using the British National Formulary 
(BNF). A dispensing error was defined as a dis-
crepancy between a correct prescription and the 
actual medication instructions that the dispensing 
pharmacist issued to the patient.
We conducted a retrospective chart review 
between May 2012 and April 2013 to ascertain 
prescription and dispensing errors among SHOs, 
resident trainees and clinical instructors attend-
ing to clients at the pediatric A&E department.
Intervention
In consultation with the AKUH department of 
information technology, a VRS was installed at 
the pediatric A&E and the main pharmacy prior 
to commencement of this study in May 2013. 
Installation entailed connecting a microphone to 
a computer based at the pediatric A&E depart-
ment and linking it to the main hospital pharmacy 
through a central server. A medical dictionary 
consisting of common medical terms obtained 
from medication records obtained in the pre-VRS 
phase was set up and stored in the computer data-
base. Doctors and pharmacists consenting to the 
use of VRS were then trained to enhance profi-
ciency in its use. Voice profiles of participating 
doctors were also installed in order to enhance 
voice recognition.
The same team of doctors enrolled patients at the 
time of medical consultation with written informed 
consent from accompanying guardians. Patients 
then physically presented the VRS prescription at 
the main pharmacy to obtain their medications. 
Dispensing pharmacists verified biodata and 
medication particulars of patients from a label 
affixed to the medication package before dispens-
ing with instructions on usage. We then analyzed 
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medication particulars on VRS prescriptions and 
their corresponding dispensing records to deter-
mine the proportion of prescription errors and dis-
pensing errors. At the end of the study, the doctors 
and pharmacists were requested to indicate 
whether they found the electronic VRS to be 
acceptable for medical prescription.
Data abstraction
Information extracted from prescription and dis-
pensing records in the period before and after 
introduction of VRS included drug name, dose, 
route, frequency and duration of treatment. The 
corresponding biodata of patients, diagnosis, pro-
fessional category of prescriber (SHO, resident or 
instructor) and time of day the prescription was 
made were retrieved from medical records and 
documented in a standard study tool.
Ethical considerations
Ethical consent procedures were reviewed and 
approved by the AKUH ethical review commit-
tee, Ref 2012/26 (V3). Written informed consent 
was obtained from parents of all participating 
study children. Consent was also obtained from 
prescribing doctors and pharmacists. Investigators 
gave non-disclosure guarantee on identities of 
participants unless with prior approval.
Errors identified at the prescription stage were 
noted and immediately rectified in consultation 
with the attending physician. Where errors were 
identified at the dispensing stage, the principal 
investigator recorded the same and informed the 
pharmacist to amend the dispensing label prior to 
dispensing the medication.
Sample size
In the absence of local information, sample size 
estimation for the number of prescriptions needed 
for analysis was based on a prior study by Kang 
and colleagues that reported 14% prevalence of 
medication errors and an error reduction of 48% 
following introduction of VRS.16 A minimum 
number of 496 in each arm was needed to provide 
90% power with a 95% confidence interval.
Data management and analysis
Information was then entered into excel tables 
secured in a password-protected computer. Each 
entry was then reassessed to ensure all variables 
were entered correctly. In the case of missing 
information, medical, prescription and dispens-
ing records were reanalyzed to capture the miss-
ing information.
Data was analyzed using STATA version 13 
(StataCorp. 2013. Stata Statistical Software: 
Release 13. College Station, TX: StataCorp LP. It 
is manufactured by StataCorp in Texas USA). 
Demographic characteristics for both phases of the 
study were summarized as frequencies and propor-
tions. The proportion of prescription or dispensing 
errors was compared between handwritten prescrip-
tions and VRS-generated prescriptions using chi-
square tests. Two sample tests for proportions were 
used to assess for significant differences in prescrip-
tion errors for periods before and after intervention 
with stratification by work shift and doctor’s desig-
nation. The Mantel-Haenszel method was used to 
estimate odds ratios (ORs) of prescription errors 
between the pre-VRS and VRS phase. Acceptability 
of VRS by healthcare providers was estimated using 
simple proportions.
Results
A total of 1196 handwritten prescription records 
were examined in the pre-VRS phase and 501 in 
the VRS phase. Table 1 illustrates the biodemo-
graphic characteristics of study participants.
In the pre-VRS phase, 74.3% of the prescriptions 
(889 of 1196) had identifiable errors compared 
with 65.7% in the VRS phase (329 of 501).
Among prescription errors analyzed, the greatest 
impact of introduction of VRS was in reduction of 
incorrect medication dose. Incorrect medication 
doses were reduced by 13.4% with use of VRS 
(p  < 0.0001). In the pre-VRS phase, 21.4% 
(256/1196) of the prescriptions had incorrect doses 
compared with only 8% (40/501) in the VRS phase 
(p < 0.0001). Unfortunately, as shown in Table 2, 
use of VRS was associated with an increase in 
errors related to documentation of drug name, 
drug frequency and duration of treatment.
There were no significant differences noted in dis-
pensing errors with use of VRS. There were 92.7% 
errors noted in the pre-VRS phase (1030 of 1111) 
compared with 93.3% in the VRS phase (332 of 
356). The use of VRS was associated with an 
increase in omission of duration of medication pre-
scription (p = 0.006). The effect of introduction of 
VRS on dispensing errors is shown in Table 3.
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Introduction of VRS was associated with a reduc-
tion in the proportion of errors noted in the after-
noon and evening shifts by 8.6% (p = 0.023) and 
13.3 % (p = 0.002), respectively. Similarly,  residents 
and SHOs demonstrated a reduction in prescription 
errors by 19.9% (p < 0.001) and 14% (p = 0.001), 
respectively, as shown in Table 4.Use of VRS was 
associated with a reduction in proportion of pre-
scription errors by 33% and 46% in the afternoon 
and evening shift, respectively. Among the various 
cadres of healthcare workers, the greatest risk reduc-
tion in errors with the use of VRS was noted among 
residents with a 61% reduction in the odds of com-
mitting prescription errors. Table 5 shows the effect 
of shift and designation on the occurrence of errors.
A total of 58% of the healthcare providers inter-
viewed (7/12) expressed desire for future use of 
Table 1. Biodemographic characteristics of study participants.
Pre-VRS During VRS Total
 n % n % n %
Sex of child
 Male 696 58.2 226 45.1 922 54.3
 Female 459 38.4 275 54.9 734 43.3
 Missing 41 3.4 0 0 41 2.4
Shift worked
 Morning 377 31.5 99 19.8 476 28
 Afternoon 391 32.7 246 49.1 637 37.5
 Evening 394 32.9 156 31.1 550 32.4
 Missing 34 2.8 0 0 34 2
Designation
 Instructor 550 46 229 45.7 779 45.9
 Consultant 13 1.1 0 0 13 0.8
 Resident 167 14 126 25.2 293 17.3
 SHO 393 32.9 146 29.1 539 31.8
 Intern 44 3.7 0 0 44 2.6
 Unknown/
missing
29 2.4 0 0 29 1.7
Age categories (years)
 0–1 281 23.5 79 15.8 360 21.2
 1–5 518 43.3 261 52.1 779 45.9
 5–10 269 22.5 133 26.6 402 23.7
 10–15 95 7.9 28 5.6 123 7.2
 Missing 33 2.8 0 0 33 1.9
Total 1196 100 501 100 1697 100
SHO, senior house officer; VRS, voice recognition system.
NOTE: The bold figures demonstrates the totals i.e if one is to add all the entries Sex of child it should add up to 1196.
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Table 2. Prescription errors before and after introduction of voice recognition system.
Pre-VRS During VRS Total  
 n % n % n % p-value
Drug name
 Correct 1163 97.2 468 93.4 1631 96.1 0.000
 Incorrect 33 2.8 33 6.6 66 3.9
Drug dose
 Correct 739 61.8 377 75.2 1116 65.8 0.000
 Incorrect 256 21.4 40 8 296 17.4
 Omitted 201 16.8 84 16.8 285 16.8
Drug route
 Correct 699 58.4 316 63.1 1015 59.8 0.206
 Incorrect 10 0.8 4 0.8 14 0.8
 Omitted 487 40.7 181 36.1 668 39.4
Drug frequency
 Correct 886 74.1 361 72.1 1247 73.5 0.000
 Incorrect 253 21.2 84 16.8 337 19.9
 Omitted 57 4.8 56 11.2 113 6.7
Drug duration
 Correct 975 81.5 409 81.6 1384 81.6 0.000
 Incorrect 83 6.9 11 2.2 94 5.5
 Omitted 138 11.5 81 16.2 219 12.9
Omission in prescription1
 No 505 42.2 237 47.3 742 43.7 0.054
 Yes 691 57.8 264 52.7 955 56.3
Incorrect prescription2
 No 684 57.2 346 69.1 1030 60.7 0.000
 Yes 512 42.8 155 30.9 667 39.3
Any prescription errors
 Correct 307 25.7 172 34.3 479 28.2 0.000
 Incorrect 889 74.3 329 65.7 1218 71.8
1Omission of indicating either drug name, dose, route frequency or duration.
2Incorrect prescription regarding either drug name, dose, route frequency or duration, excluding omissions.
VRS, voice recognition system.
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Table 3. Dispensing errors before and after introduction of voice recognition system.
Pre-VRS During VRS Total  
 n % n % n % p-value
Drug name
 Correct 1074 96.7 334 93.8 1408 96 0.017
 Incorrect 37 3.3 22 6.2 59 4
Drug dose
 Correct 765 68.9 264 74.2 1029 70.1 0.006
 Incorrect 208 18.7 41 11.5 249 17
 Omitted 138 12.4 51 14.3 189 12.9
Drug route
 Correct 516 46.4 156 43.8 672 45.8 0.688
 Incorrect 9 0.8 3 0.8 12 0.8
 Omitted 586 52.7 197 55.3 783 53.4
Drug frequency
 Correct 803 72.3 242 68 1045 71.2 0.246
 Incorrect 196 17.6 69 19.4 265 18.1
 Omitted 112 10.1 45 12.6 157 10.7
Drug duration
 Correct 232 20.9 56 15.7 288 19.6 0.006
 Incorrect 27 2.4 2 0.6 29 2
 Omitted 852 76.7 298 83.7 1150 78.4
Dispensing omission1
 No 115 10.4 27 7.6 142 9.7 0.124
 Yes 996 89.6 329 92.4 1325 90.3
Incorrect dispensing2
 No 708 63.7 235 66 943 64.3 0.434
 Yes 403 36.3 121 34 524 35.7
Dispensing errors
 Correct 81 7.3 24 6.7 105 7.2 0.726
 Incorrect 1030 92.7 332 93.3 1362 92.8
Total (n) 1111 356 1467  
1Omission of indicating either drug name, dose, route frequency or duration when dispensing.
2Incorrect dispensing regarding either drug name, dose, route frequency or duration, excluding omissions.
VRS, voice recognition system.
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VRS in the medication process. Some of the 
advantages noted by healthcare providers in 
using VRS were that it saved time during the pre-
scription process and reduced errors associated 
with illegibility. Pharmacists observed that dic-
tion was a challenge in the utilization of VRS as 
they often had to log on to a separate online sys-
tem to access VRS-generated prescriptions, 
which was perceived to increase workload.
Five out of twelve of the healthcare providers pro-
posed incorporation of VRS into the hospital 
online information system, while one recom-
mended expansion of the medical dictionary 
within the VRS to allow for comprehensive iden-
tification of medical terms. Other proposals made 
were to incorporate a prescription template and 
an online drug list within the software to auto-
mate dosages, route and frequency.
Table 4. Proportion of prescription errors by shift and designation of doctors.
Pre-VRS During VRS Total p-value
 n % n % n %
Shift
 Morning 284 75.3 76 76.8 360 75.6 0.767
 Afternoon 286 73.2 159 64.6 445 69.9 0.023
 Evening 290 73.6 94 60.3 384 69.8 0.002
Designation
 Instructor 402 73.1 166 72.5 568 72.9 0.863
 Resident 130 77.8 73 57.9 203 69.3 0.000
 SHO 297 75.6 90 61.6 387 71.8 0.001
SHO, senior house officer; VRS, voice recognition system.
Table 5. Overall risk of prescription errors by shift and designation of doctors.
Odds ratio 95% CI
Crude 0.66 0.53 0.83
Shift worked
 Morning 1.08 0.64 1.82
 Afternoon 0.67 0.48 0.95
 Evening 0.54 0.37 0.80
M-H combined 0.69 0.55 0.87
Designation
 Instructor 0.97 0.69 1.37
 Resident 0.39 0.24 0.65
 SHO 0.52 0.35 0.78
M-H combined 0.65 0.52 0.82
CI, confidence interval; M-H, Mantel-Haenszel; SHO, senior house officer.
Therapeutic Advances in Drug Safety 00(0)
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Discussion
This study was conducted in a pediatric A&E 
department of a private, not-for-profit, tertiary 
healthcare facility to primarily establish if intro-
duction of a VRS would reduce medication errors. 
We demonstrated that overall, 74.3% (889 of 
1196) of prescriptions in the pre-VRS phase had 
errors compared with 65.7% (329 of 501) in the 
VRS phase. These are unacceptably high error 
rates which may be attributed to how medication 
error was defined. Our study did not, for instance, 
include missing or wrong patient weight and errors 
in prescription dates in the list of errors. Kang and 
colleagues, using a similar VRS system on pathol-
ogy reporting observed 48% reduction in errors.15 
Further studies are required to ascertain how best 
to incorporate VRS within already existing health 
systems to maximize on its benefits.
In this study, the greatest impact of VRS intro-
duction was in reduction of incorrect drug dos-
age. This advantage was, however, countered by 
an increase in wrong documentation of drug 
name, and failure to indicate frequency and dura-
tion of treatment. Our study, however, was not 
powered for a detailed subanalysis of the many 
variables in this study. These serious prescription 
omissions and commissions may be attributed to 
inadequacy in staff training and experience in 
using the new system. Antiles and colleagues 
indeed emphasized how crucial training and 
experience are for the successful use of the tech-
nology.17 Errors may also have been minimized if 
the VRS had been programmed to make it man-
datory for all critical information to be entered 
before the user could proceed with the prescrip-
tion process. Automation of dosages computed 
from weight or age entries could reduce errors 
even further. Fortunately, we did not find any 
incident of administering medications to the 
wrong patient during the study period.
The greatest impact of reduction in prescription 
errors was noted among residents and SHOs. 
This may be accounted for by the fact that junior 
doctors are yet to establish their prescription hab-
its and patterns. Consequently, they readily take 
up new practices to improve prescription habits. 
Implementation of VRS reduced the prescription 
errors occurring in the afternoon and evening shifts. 
We postulate that this was due to the fact that most 
of these shifts were done by residents and SHOs.
The majority of our study respondents preferred 
VRS prescriptions compared with handwritten 
prescriptions. They were of the view that VRS 
reduced prescription illegibility, was user friendly 
and saved time. Diction was, however, of concern 
to dispensing pharmacists and will require further 
studies to provide software solutions.
In hospitals without online prescribing systems, 
patient information is typically dispersed in a col-
lection of paper records that are poorly organized, 
illegible, and not easy to retrieve.7 Thus, informa-
tion technology holds untapped potential for 
improving efficiency in healthcare delivery sys-
tems with positive impact on service quality and 
client satisfaction. Since VRS software can be 
downloaded from the internet at no cost, incor-
poration of VRS into hospital systems should be 
considered when facilities undertake digitaliza-
tion of patient data. Equipment procurement, 
setup and maintenance may still be cost effective, 
given the high cost of manual record keeping and 
risk of serious harm to patients. The effect of 
more intensive training and close prescription 
monitoring with feedback warrants further study 
in efforts to lower error rates associated with use 
of the electronic system. Our study was not 
designed to assess cost effectiveness of VRS but 
we recommend that future studies ascertain the 
cost effectiveness of the free VRS software in the 
medication process.
Before–after trials have the inherent drawback of 
inability to control for changes that may take 
place over time and which would be beyond the 
control of investigators. A randomized trial would 
be preferable in assessment of effectiveness of 
VRS. However, in a relatively small A&E unit, 
with 11 full-time staff doing different shifts, it 
would present challenges, as blinding would not 
be possible. Implementation of VRS poses vari-
ous logistical challenges too. During the study, it 
was not possible to integrate the existing phar-
macy online system with the VRS due to software 
incompatibility. Despite creating a medical dic-
tionary within the VRS, repeated trials at dicta-
tion and editing of medical terms were required 
during its use. Consequently, the greatest disad-
vantage cited by dispensing pharmacists during 
this study was diction that may have contributed 
to increased incidence in incorrect drug name 
entry in the VRS phase. Local customization of 
software that takes diction into account requires 
further exploration.
While acknowledging VRS prescription per-
formed well below our expectation, our findings 
AN Migowa, WM Macharia et al.
journals.sagepub.com/home/taw 9
demonstrate the potential of using modern infor-
mation technology to improve patient safety, pro-
vided areas of concern that we have highlighted 
are systematically addressed. As the Chair of the 
Committee on Quality of Health Care in America 
states, limited awareness on the magnitude of 
medication errors and extent to which healthcare 
professionals have fallen short of making optimal 
use of technology to improve healthcare safety 
explains in part the slow uptake of technology in 
the medication process.7 We hope that similar 
larger studies will lead to improvement in quality 
of medical prescription electronic software.
Conclusion
Implementation of VRS in the medication pro-
cess has the potential to reduce medication errors, 
with the greatest impact noted particularly in 
reduction of incorrect dosages. Further research 
is recommended to determine if more user train-
ing, experience, close monitoring of prescriptions 
and software improvement will minimize draw-
backs associated with VRS. Since VRS can be 
downloaded from the internet at no cost and 
appears to be acceptable to prescribing physicians 
and dispensing pharmacists, further studies 
should be undertaken to improve performance 
and assess cost effectiveness.
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